WHO ICTRP trial
Study on the mechanism of inflammation mediated by anti-collagen antibody…
ChiCTR2400094784 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400094784 |
|---|---|
| Public title | Study on the mechanism of inflammation mediated by anti-collagen antibody complex involved in the formation of pathological myopia |
| Scientific title | Study on the mechanism of inflammation mediated by anti-collagen antibody complex involved in the formation of pathological myopia |
| Primary sponsor | Tianjin Eye Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Pathological myopia |
| Interventions | Pathological myopia group:None;Experimental control group:None |
| Registration date | Dec 27, 2024 |
| Target size | Pathological myopia group:20;Experimental control group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: